title: Electron therapy for orbital and periorbital lesions using customized lead eye shields.
abstract: OBJECTIVE
  To establish the protective efficacy against late complications of electron therapy using customized lead eye shields in cases with orbital and periorbital lesions.
  
  
  METHODS
  Between 1982 and 2006, 16 patients with 22 orbital and periorbital lesions were treated by electron therapy. Customized lead eye shields were prepared and placed in the respective patients' eyes during each fraction of electron therapy. The toxicity and local control rates were analyzed.
  
  
  RESULTS
  The preparation period for the customized lead eye shields was 2 days. The shields could be used throughout the treatment period in all the patients. No evidence of radiation cataract was observed in 15 of the 16 patients. None of the patients developed corneal ulceration or evidence of lead poisoning.
  
  
  CONCLUSIONS
  Customized lead eye shields could be made relatively quickly, and electron therapy for orbital and periorbital lesions could be undertaken safely without any late complication.
authors.affiliation: Department of Radiology, Tokyo Medical and Dental University, Japan. kjh@hte.highway.ne.jp
authors.forename: Keiji
authors.initials: K
authors.lastname: Hayashi
authors.forename: Kunito
authors.initials: K
authors.lastname: Hatsuno
authors.forename: Ryo-ichi
authors.initials: R
authors.lastname: Yoshimura
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Iida
authors.forename: Fumio
authors.initials: F
authors.lastname: Ayukawa
authors.forename: Kazuma
authors.initials: K
authors.lastname: Toda
authors.forename: Hisashi
authors.initials: H
authors.lastname: Taniguchi
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Shibuya
mesh_terms: D000230:Adenocarcinoma / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004583:Electrons; D004867:Equipment Design; D005135:Eye Protective Devices; D005142:Eyelid Neoplasms / Q000532:radiotherapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007854:Lead; D008223:Lymphoma / Q000532:radiotherapy*; D008297:Male; D008537:Meibomian Glands; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000532:radiotherapy*; D011835:Radiation Protection / Q000295:instrumentation*; D011878:Radiotherapy / Q000379:methods*
chemical_list: D007854:Lead